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Abstract 
Uncontrolled HH/GLI and WNT/β-catenin signaling are important events in the genesis 
of many cancers including skin cancer and are often implicated in tumour progression, 
invasion and metastasis. However, due to the complexity and context-dependency of both 
pathways, little is known about HH and WNT interactions in human carcinogenesis. In 
the current study we provide evidence of HH/GLI2-WNT/β-catenin signaling crosstalk in 
human keratinocytes. Over-expression of GLI2ΔN in human keratinocytes resulted in 
cytoplasmic accumulation and nuclear relocalization of β-catenin in vitro and in 
3D-organotypic cultures, accompanied by upregulation of WNT genes. Induction of 
GLI2ΔN, enhanced the β-catenin-dependent transcriptional activation and the subsequent 
activation of β-catenin target genes including Cyclin-D1. Additionally, GLI2 
overexpression was associated with decreased E-cadherin protein levels, increased 
expression of SNAIL, MMP2 and integrin β1, and with increased cell invasion in 3D-
organotypic cultures. Invasion was reduced by Wnt inhibition, thus unveiling direct role 
of GLI2/Wnt crosstalk in cell invasion. We also showed that GLI2 supported long-term 
epidermal regeneration in 3D-organotypic cultures and induced an undifferentiated 
basal/stem cell-associated phenotype, in line with the role of β-catenin and SNAIL in 
epidermal stem cell maintenance. This work suggests that GLI2 is a regulator of 
β-catenin and provides insights into its role in tumourigenesis. 
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Introduction 
The Hedgehog (HH) signaling pathway is highly conserved in embryonic development, 
while its constitutive activation is implicated in basal cell carcinomas (BCCs), 
medulloblastomas, glioma and rhabdosarcoma development (Aberger and Ruiz, 2014, 
Beachy et al. , 2004, Gorlin, 1995, Ruiz i Altaba et al. , 2002). GLI2 is the key 
transcriptional effector of the HH pathway and probably the major mediator of malignant 
transformation induced by the loss of PTCH1 in BCC (Li et al. , 2014, Pantazi et al. , 
2014, Yin et al. , 2015).  
 
GLI2 up-regulation is frequently observed in human BCCs (Ikram et al. , 2004, 
O'Driscoll et al. , 2006, Regl et al. , 2004b, Tojo et al. , 2003), while its targeted 
constitutive overexpression in transgenic mice causes BCC formation and is required for 
BCC maintenance (Grachtchouk et al. , 2000, Hutchin et al. , 2005). GLI2  is also 
consistently up-regulated in aggressive cancers (Ruiz i Altaba, Sanchez, 2002, 
Thiyagarajan et al. , 2007, Zhang et al. , 2013) and is associated with invasion and 
metastasis (Alexaki et al. , 2010, Javelaud et al. , 2011, Marsh et al. , 2008, Snijders et al. 
, 2008, Sterling et al. , 2006). Using an in vitro model of human BCC, we showed that 
GLI2 suppresses cell cycle regulators, inhibits apoptosis, and induces genomic instability 
(Pantazi, Gemenetzidis, 2014). 
 
B-catenin is the major and downstream effector of the canonical WNT signaling pathway 
(Behrens et al. , 1996). Transactivation of WNT target genes have been linked to tumor 
formation, invasion and metastasis (Marchenko et al. , 2002, Polakis, 2000). In mice, 
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β-catenin controls hair follicle morphogenesis and stem cell differentiation (Huelsken et 
al. , 2001), while its inappropriate activation promotes the formation of follicle and 
BCC-like tumors (Gat et al. , 1998, Nicolas et al. , 2003).  
 
HH/GLI2-driven human BCCs show increased levels of WNT genes such as WNT2B, 
WNT5A, WNT7A and WNT11 (Bonifas et al. , 2001, Mullor et al. , 2001, O'Driscoll, 
McMorrow, 2006, Saldanha et al. , 2004, Yu et al. , 2008), accumulation of cytoplasmic 
and nuclear β-catenin (El-Bahrawy et al. , 2003, Papanikolaou et al. , 2010, Saldanha, 
Ghura, 2004, Yamazaki et al. , 2001, Yang et al. , 2008) and increased mRNA levels of 
the matrix metalloproteinases (MMP), which are known targets of β-catenin-TCF/LEF-1 
signaling (O'Driscoll, McMorrow, 2006, Sternlicht et al. , 1999, Yu, Zloty, 2008). 
 
Due to the complexity and context-dependency of both HH and WNT pathways little is 
known about HH and WNT interactions in human carcinogenesis. In the current study we 
provide evidence of HH/GLI2-WNT/β-catenin signaling crosstalk in human 
keratinocytes. Over-expression of GLI2ΔN in N/TERT human keratinocytes, promotes 
nuclear relocalization and enhanced transcriptional activation of β-catenin, as well as loss 
of E-cadherin protein expression, increased SNAIL, MMP2 and integrin β1 expression, 
increased cell invasion and long-term epidermal regeneration in organotypic cultures. We 
propose that GLI2 is a regulator of β-catenin and provide insights into its role in 
carcinogenesis and tumour progression. 
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Results 
GLI2ΔN promotes nuclear re-localization of β-catenin and induces β-catenin 
dependent transactivation in human keratinocytes 
Β-catenin re-localization to the nucleus is a necessary step for the transcriptional 
activation of its downstream genes and is tightly controlled. To investigate whether 
GLI2ΔN expression can alter the sub-cellular distribution of β-catenin control N/TERT 
EGFP (SINCE) and EGFP-GLI2ΔN (SINEG2)-expressing keratinocytes were seeded at 
equal densities and harvested for cytoplasmic and nuclear protein fractions. Increased 
nuclear and decreased cytoplasmic β-catenin, was observed in SINEG2 cells compared to 
SINCE keratinocytes (Figure 1a, b, d), Overall levels of β-catenin were similar in both 
SINCE and SINEG2 keratinocytes (Figure 1c).  
 
To investigate whether the increased nuclear β-catenin is transcriptionally active, we used 
(Supplementary Materials and Methods) the well characterized OT-β-catenin responsive 
promoter (OT), an improved version of TOPFLASH (Shih et al. , 2000). 
GLI2ΔN-expressing keratinocytes showed a significant increase in the transactivation of 
β-catenin compared to N/TERT and SINCE control cells (Figure 1e). Cyclin-D1, a 
β-catenin-regulated gene (Shtutman et al. , 1999, Tetsu and McCormick, 1999) was also 
upregulated (Supplementary Figure S1). 
 
We confirmed these data using inducible GLI2ΔN-expressing keratinocytes (NTEG2) 
(see Supplementary Material Methods, Supplementary Results, Supplementary 
Figure S2, S3a). Β-catenin transcriptional activation was significantly increased in 
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NTEG2 (Dox-) keratinocytes compared to both NTEG2 (Dox+) and N/TERT control 
cells (Supplementary Figure S3b). Immunoblotting for EGFP and active β-catenin 
(Supplementary Figure S3c) showed that active β-catenin was significantly higher in the 
induced NTEG2 cells compared to control cells. 
 
Induction of multiple WNT ligands upon GLI2ΔN expression in N/TERT 
keratinocytes 
WNT genes are activated during embryonic development upon Gli2 induction and in 
human BCCs (Bonifas, Pennypacker, 2001, Mullor, Dahmane, 2001, Yu, Zloty, 2008), 
where GLI2 is highly expressed.  
 
Stable expression of GLI2ΔN in human keratinocytes resulted in the upregulation of 
WNT5A (Figure 2a), WNT7A (Figure 2b) and WNT11 (Figure 2c), compared to 
wild-type and EGFP-expressing N/TERT keratinocytes. The relative fold mRNA 
induction of WNT11 could be an overestimation, due to the very low background levels 
of WNT11 mRNA observed in control N/TERT and SINCE keratinocytes (Ct >31). 
 
Stable GLI2ΔN expression in N/TERT keratinocytes induces downregulation of 
E-cadherin protein expression and upregulation of EMT markers 
Immunoblotting analysis showed a significant reduction of E-cadherin in SINEG2 cells, 
compared to control N/TERT and SINCE keratinocytes (Figure 3a). Loss of E-cadherin is 
believed to promote loss of cell-cell adhesion and release of the membranous β-catenin to 
the cytoplasm (Canel et al. , 2013), and is associated with epithelial-mesenchymal 
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transitions (EMT) both during development and during tumour progression (Cavallaro 
and Christofori, 2004, Hugo et al. , 2007, Nelson and Nusse, 2004, Thiery, 2002). The 
EMT markers SNAIL1 and SNAIL2 both suppress E-cadherin (Batlle et al. , 2000, Hajra 
et al. , 2002). We showed by quantitative real-time PCR (qRT-PCR) analysis that stable 
expression of GLI2ΔN in human N/TERT keratinocytes, results in up-regulation of 
SNAIL1 (Figure 3b), and to a lesser extent of SNAIL2 (Figure 3c). The levels E-cadherin 
mRNA remained unchanged (Figure 3d), despite E-cadherin protein down-regulation 
(Figure 3a), suggesting that the down-regulation of E-cadherin protein in SINEG2 cells 
might be a result of post-translational processes.   
 
Increased capacity of GLI2ΔN-expressing cells to invade collagen/matrigel gels 
Nuclear active β-catenin, loss of E-cadherin and up-regulation of both WNT and SNAIL, 
are implicated in cancer cell invasion and metastasis. Haematoxylin and eosin (H&E) 
(Figure 4a), cytokeratin and DAPI staining (Figure 4b) showed that N/TERT and SINCE 
controls produced a stratified epithelium with no cell invasion (Figure 4a and Figure 4b). 
In contrast, SINEG2 cells, produced a thicker, poorly differentiated epithelium with 
clusters of basal-like cells invading into the upper region of the collagen layer, 
recapitulating the histopathology of nodular and superficial human BCC. SINEG2 cells 
also invaded as protrusive multicellular strands with a blunt bud-like tip that remained in 
connection with the overlying epidermis (Figure 4b; SINEG2 panels), similar to hair 
follicle bud formation. Cytokeratin staining (red) of the epithelium was uniform in all 
organotypics (Figure 4b). Quantification of invasive cells (as described in materials and 
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methods) showed that SINEG2 keratinocytes were significantly more invasive compared 
to control cells (Figure 4c).  
 
MMP2, which is a known target of β-catenin-TCF/LEF-1 (Wu et al. , 2007), was 
significantly increased mRNA levels, as shown by qRT-PCR, and protein levels, as 
shown by MPP2 staining in SINEG2 organotypic cultures especially at the periphery of 
invading multicellular strands and clusters (Supplementary Figure S4a, b). We then 
repeated the organotypic cultures for a period of 14 days, with continuous treatment of 
human recombinant sFRP-1, which acts as an antagonist of WNT signaling. Although 
SINEG2 cells treated with sFRP-1 produced a similar basal-like undifferentiated 
epithelium, cells displayed a reduced capacity for invasion into the organotypic ECM 
(Figure S5).  
 
Loss of membranous E-cadherin and β-catenin expression in GLI2ΔN organotypic 
cultures 
Loss and/or fragmentation of membranous E-cadherin and β-catenin, as well as altered 
cellular distribution of β-catenin were also observed in organotypic cultures of 
GLI2ΔN-expressing cells at 14 days, supporting our immunoblotting data. 
Immunohistochemistry for E-cadherin, showed strong and complete membranous 
expression in SINCE control cells (Figure 5a). However, E-cadherin staining was 
fragmented or lost in SINEG2 cells in the upper epithelium as well as in invading cells, 
and especially at the periphery of invading cells (Figure 5a; SINEG2 panels). 
Immunohistochemistry for β-catenin showed strong continuous membranous staining in 
 11 
SINCE control cells, while SINEG2 cells exhibited partial or complete loss of 
membranous β-catenin staining (Figure 5b, c). This pattern was associated with weak 
diffuse cytoplasmic and/or focally nuclear staining in SINEG2 cells, and was observed 
both in the upper epithelium, as well as in the invading GLI2ΔN-expressing cells, with 
only few cells retaining the membranous β-catenin stain. 
 
GLI2ΔN-expressing cells support long-term epidermal regeneration in organotypic 
cultures and display an undifferentiated basal stem-cell like phenotype in vitro  
Prolonged culture of N/TERT and SINCE organotypic for 28 days showed marked 
epidermal atrophy (Figure 6a, b), which is consistent with the limited regenerative 
potential of keratinocytes grown on a collagen gels (Muffler et al. , 2008, Stark et al. , 
1999). In contrast, SINEG2 cells retained a stratified epithelium at 28 days (Figure 6a; b), 
and maintained the capacity for deep invasion into the ECM (Figure 6c-e)  
 
Lack of atrophy in GLI2ΔN keratinocytes may be due to impaired differentiation, and/or 
due to maintenance of a basal/stem cell phenotype. This was confirmed in vitro by the 
down-regulation of involucrin in SINEG2 cells (Figure 6f), as well as of c-MYC 
(Figure 6g, j), which is another marker of keratinocyte differentiation (Gandarillas and 
Watt, 1997). Integrin β1, a marker for the enrichment of epidermal keratinocyte stem 
cells (Jones et al. , 1995, Jones and Watt, 1993, Zhu et al. , 1999), was increased in 
SINEG2 keratinocytes compared to control cells (Figure 6h). Similar changes have been 
reported in human BCCs (Daya-Grosjean and Couve-Privat, 2005, Miller, 1991, 
O'Driscoll, McMorrow, 2006, Youssef et al. , 2010). Finally, SOX2 a well-characterized 
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stem cell associated gene (Fong et al. , 2008, Masui et al. , 2007, Niwa, 2007), was 
markedly up-regulated in SINEG2 keratinocytes, compared to controls (Figure 6i), 
although the relative fold mRNA induction could have been overestimated due to the low 
SOX2 mRNA copy number in control keratinocytes (Ct >31). 
 
Discussion 
The HH and WNT pathways play pivotal roles in development and stem cell maintenance 
and are implicated in the etiology of a range of cancers including BCC. The crosstalk 
between these pathways has not been fully investigated in human cells, although targeted 
inhibition makes them attractive therapeutic targets. Here we provide evidence of 
HH/GLI2 crosstalk with the WNT/β-catenin pathway in human keratinocytes and more 
evidence for the role of GLI2 in key aspects of tumourigenesis. Overexpression of the 
constitutively active form of GLI2 (GLI2ΔN), in N/TERT human epidermal 
keratinocytes, promoted cytoplasmic accumulation and nuclear re-localization of 
β-catenin, and enhanced its transcriptional activation. This was associated with loss of 
E-cadherin protein expression, cell invasion and long-term epidermal regeneration in 
organotypic cultures. 
 
β-catenin, the downstream mediator of the Wnt pathway, is usually confined to the cell 
membrane in an adhesion complex including E-cadherin (Nelson and Nusse, 2004). Its 
cytoplasmic concentration in the absence of WNT activation remains low and its nuclear 
relocalization and transcriptional activity is tightly regulated. Activation of β-catenin is 
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strongly implicated in carcinogenesis, invasion, EMT, and metastasis (Brabletz et al. , 
2005, Kim et al. , 2002, Klaus and Birchmeier, 2008). 
 
We provide evidence of cytoplasmic stabilization and nuclear accumulation of β-catenin, 
induced by overexpression of GLI2ΔN in N/TERT human keratinocytes. The loss of 
membranous β-catenin and its altered localization was also observed after GLI2ΔN 
expression in 3D organotypic cultures and resembles the expression pattern of β-catenin 
in human BCCs (El-Bahrawy, El-Masry, 2003, Papanikolaou, Bravou, 2010, Saldanha, 
Ghura, 2004, Yamazaki, Aragane, 2001, Yang, Andl, 2008), HH/GLI2-driven tumours. 
Induction of WNTs was also observed in GLI2ΔN-expressing cells suggesting that WNT 
expression in human BCCs may be regulated by GLI2.  
 
Furthermore, we showed by reporter assay as well as by upregulation of the β-catenin 
target gene Cyclin-D1 that β-catenin re-localization to the nucleus results in its 
transcriptional activation, both in stable and inducible GLI2ΔN-expressing cells. 
Interestingly, the direct upregulation of SOX2 by GLI2ΔN shown here and in other 
studies (Santini et al. , 2014, Snijders, Huey, 2008, Takanaga et al. , 2009), may further 
enhance β-catenin-mediated transcriptional activation in GLI2-expressing cells, as SOX2 
is a transcription partner for β-catenin, acting in synergy to transcriptionally regulate 
Cyclin-D1, in breast cancer cells (Chen et al. , 2008). Furthermore, it has been shown that 
β-catenin is recruited to the promoter of GLI2 in response to TGF-β, which raises the 
possibility that there may be an amplification loop whereby GLI2 promotes β-catenin 
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translocation to the nucleus which in turn activates GLI2 transcription (Dennler et al., 
2009). 
 
c-MYC, an established target of β-catenin in colon cancer cells (He et al. , 1998, Klaus 
and Birchmeier, 2008), was downregulated in GLI2-expressing keratinocytes, and has 
been shown previously to be downregulated in GLI2-expressing rat kidney and HaCaT 
epithelial cells (Eichberger et al. , 2006, Li et al. , 2007, Regl et al. , 2004a). This pattern 
is consistent with the reduced expression of c-MYC in human BCCs (Asplund et al. , 
2008, Bonifas, Pennypacker, 2001, O'Driscoll, McMorrow, 2006, Regl et al. , 2002).  
 
Activation of WNT/β-catenin pathway by GLI2ΔN suggests that β-catenin can be a 
downstream effector of SHH/GLI2 pathway and that in human keratinocytes GLI2 is a 
regulator of β-catenin. In agreement, canonical WNT/β-catenin signaling is essential for 
the tumorigenic response to deregulated HH signaling, in mice and humans (Roop and 
Toftgard, 2008, Yang, Andl, 2008).  
 
GLI2 was shown to affect the protein levels of E-cadherin, which is downregulated in 
many cancers including human BCCs (Papanikolaou, Bravou, 2010) and is a prerequisite 
for cell transformation, EMT, cancer cell invasion, tumour progression and metastasis 
(Birchmeier and Behrens, 1994, Canel, Serrels, 2013, Cavallaro and Christofori, 2004, 
Li, Deng, 2007, Nakajima et al. , 2004). Additionally, high expression of GLI2 together 
with loss of CDH1 expression is found in melanoma cell lines with a gene expression 
profile reminiscent of a TGF-b signature that exhibit a strongly invasive phenotype (Hoek 
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et al. , 2006, Widmer et al. , 2012). In the same context, GLI2 up-regulates and 
co-operates with ZEB1 to induce CDH1 gene silencing, while GLI2 knock-down restores 
the levels of CDH1expression (Perrot et al. , 2013). GLI2ΔN-expressing cells also show 
increased expression of EMT markers SNAIL1 and SNAIL2, which are both 
transcriptional repressors of the E-cadherin gene (Batlle, Sancho, 2000, Hajra, Chen, 
2002). However, in N/TERT epidermal keratinocytes, GLI2ΔN overexpression did not 
alter the levels of E-cadherin mRNA transcription. It’s possible that in N/TERT cells, 
which retain a normal epithelial differentiation profile, CDH1 expression is tightly 
regulated and that the reduction of CDH1 protein levels is largely a result of 
post-translational modification. This is in agreement with other studies where the 
mechanisms through which SNAIL1 regulates E-cadherin expression are context-specific 
and in which SNAIL enhances the degradation of E-cadherin protein (Kume et al. , 2013, 
Stemmer et al. , 2008). Additionally, the upregulation of SNAIL1 upon GLI2ΔN 
induction could also affect and enhance the transcriptional activity of β-catenin, since 
SNAIL1 has been shown to bind and act as a co-activator of β-catenin (Stemmer, de 
Craene, 2008). Moreover, targeted overexpression of SNAIL in mice causes skin cancer 
including BCC formation, while human BCC show increased expression of SNAIL (De 
Craene et al. , 2014, Papanikolaou, Bravou, 2010). E-cadherin is the main mediator of 
cell-cell adhesion and is usually tethered with β-catenin in the epithelial cell membrane. 
Therefore, its reduced expression upon GLI2ΔN induction, observed both in vitro and in 
organotypic cultures in our study, suggests its possible contribution to the accumulation 
of β-catenin in the cytoplasm due to release of the membranous β-catenin to the 
cytoplasm, followed by its subsequent translocation to the nucleus.  
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E-cadherin cleavage, followed by loosening of AJs and β-catenin redistribution, along 
with WNT and SNAIL upregulation, which resulted from GLI2 expression, may have 
implications for both carcinogenesis and invasion. GLI2ΔN keratinocytes invaded 
organotypic cultures as clusters and multicellular strands, in a manner that recapitulates 
the histopathology of nodular and superficial human BCC and that is histologically 
similar to hair buds, for which activation of WNT/β-catenin signaling is required (Yang, 
Andl, 2008). GLI2 may therefore play a direct role in driving cell invasiveness. Both 
integrin β1, which mediates focal adhesions, and MMP2 which degrades extracellular 
matrix (ECM) and is a known target of β-catenin signaling (Wu, Crampton, 2007), were 
found to be upregulated, especially at the edges of migratory/invasive cells. Both proteins 
are reported to play major roles in cell migration, invasion and metastasis (Canel, Serrels, 
2013, Friedl and Alexander, 2011, Yilmaz and Christofori, 2010). GLI2ΔN 
overexpressing cells showed diminished invasion capacity in the presence of sFRP-1, 
with only a minority of the keratinocytes detaching from the epithelium to invade the 
organotypic ECM. Secreted sFRP-1 proteins act as WNT signaling antagonists, 
suppressing canonical β-catenin signaling, either by interacting with WNT proteins to 
prevent them from binding to Frizzled (Fz), or by forming non-functional complexes with 
Fz (Kawano and Kypta, 2003). This supports the idea that GLI2 promotes the invasive 
phenotype of human keratinocytes, partly by the up-regulation of secreted WNT proteins, 
which stimulate canonical WNT/β-catenin signaling. In glioma, a GLI-associated tumour, 
the infiltrative phenotype is associated with sFRP-1 inhibition and WNT signaling 
activation (Delic et al. , 2014), while ectopic sFRP-1 reduces glioma cell invasion in vitro 
(Roth et al. , 2000). Furthermore, WNT5A and MMP-2, which we report to be up-
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regulated by GLI2 in human keratinocytes, are both linked to the stimulation of glioma 
cell infiltration (Kamino et al. , 2011). 
 
Finally, we have shown that GLI2 is able to support long-term epidermal regeneration in 
organotypic cultures. This may be via the maintenance of an undifferentiated basal/stem 
cell-associated phenotype, resembling that of human BCCs (Crowson, 2006, Miller, 
1991, O'Driscoll, McMorrow, 2006, Youssef, Van Keymeulen, 2010). This was 
associated with down-regulation of keratinocyte differentiation and up-regulation of stem 
cell markers, including the highly tumorigenic SOX2 embryonic stem cell marker, 
(Santini, Pietrobono, 2014), and is in line with previous studies (Regl, Kasper, 2004a, 
Snijders, Huey, 2008). Previously we have shown that GLI2 promotes the survival of 
genetically unstable keratinocytes by disabling apoptotic mechanisms and deregulating 
cell cycle proteins such as p21
WAF1/CIP1
 and 14-3-3σ (Pantazi, Gemenetzidis, 2014). 
Importantly, both proteins have been implicated in the maintenance of epidermal stem 
cells and are associated with a reduced commitment to differentiation (Dellambra et al. , 
2000, Dotto, 2000, Topley et al. , 1999).  
 
Active WNT/β-catenin signaling is known to play an important role in maintaining 
normal epidermal (Beachy, Karhadkar, 2004, Klaus and Birchmeier, 2008, Nusse et al. , 
2008, Reya and Clevers, 2005, Zhu and Watt, 1999) and cancer stem cells (Malanchi et 
al. , 2008). Moreover, enhanced expression of Snail contributes to the stabilization, 
expansion and survival of skin stem cells resulting in both skin tumor initiation and 
malignant progression in mice (De Craene, Denecker, 2014). Therefore, the accumulation 
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of nuclear β-catenin and its enhanced transactivation, along with the SNAIL 
upregulation, may act synergistically and contribute to the ability of GLI2ΔN to support 
long-term epidermal regeneration in organotypic cultures and to induce an 
undifferentiated basal/stem cell-associated phenotype. 
 
In conclusion, we show that GLI2ΔN is a regulator of β-catenin in human keratinocytes 
and that its expression supports long-term epidermal regeneration and promotes an 
invasive undifferentiated basal/stem cell like phenotype with EMT traits. These include 
the loss of E-cadherin, upregulation of SNAIL, as well as enhanced MMP2 and integrin 
β1 expression. Altogether, this evidence provide valuable insights into the role of GLI2 in 
carcinogenesis and tumour progression. Knowledge of the HH/GLI2-WNT/β-catenin 
crosstalk may also help to identify potential new targets for therapy.  
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Materials and Methods 
Cell lines and culture 
Plasmids used to produce cell lines are described in Supplementary Material and 
Methods. Human telomerase (h/TERT)-immortalised N/TERT-1 (N/TERT) were 
supplied by Prof. James Rheinwald (Department of Dermatology, Harvard University 
Medical School, Boston). N/TERT keratinocytes and N/TERT stably expressing EGFP 
(SINCE) or EGFP-GLI2ΔN (SINEG2) fusion protein were as previously described 
(Pantazi, Gemenetzidis, 2014), as were Phoenix (human embryonic epithelial 293T 
derived) cells supplied by Nolan Lab (Medical Center, Stanford University Medical 
School, CA). NTERT, SINCE and SINEG2 cells were transduced with the 
pSIN-OT-Luciferase (pSIN-OT-Luc) plasmid, to produce reporter stable 
(N/TERT-OTLuc, SINCE-OTLuc and SINEG2-OTLuc, respectively) cell lines. Reporter 
stable cell lines were propagated in RM+ growth medium. Primary human foreskin 
fibroblasts (HFF) were supplied by Prof. John Marshall (Department of Tumour Biology, 
Barts Cancer Institute, London) and were cultured as previously described (Shamis et al. , 
2011). All cells were grown at 37
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. Informed written consent was obtained from all individuals who 
donated skin biopsies and collaborating dermatologists performed the biopsies at the 
Royal London Hospital (London, U.K.).  The East London and City Health Authority 
Research Ethics Committee approved the use and protocols for obtaining patient skin 
biopsies (08/H0704/65). 
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Retroviral infection 
Transductions using pSIN based constructs were carried out as previously described 
(Pantazi, Gemenetzidis, 2014).  
 
Fluorescent Activated Cell Sorting (FACS)  
FACS runs were performed in a BD FACSAria Cell Sorter fitted with a Blue Argon 
Laser 488nm, violet diode 405nm, and red diode 633nm (BD Biosciences, San Jose, CA) 
as previously described (Pantazi, Gemenetzidis, 2014).  
 
Light and Fluorescence Microscopy 
Cells were visualised using a light fluorescence microscope (Leica DM IRB/Nicon 
Eclipse TE-2000-S, Leica Microsystems, Germany). Images were captured with a digital 
imaging system (Leica DC2000 camera). 
 
Reverse Transcription PCR 
RNA was extracted from cells using RNeasy Mini Kit (Qiagen, West Sussex, UK) and 
was reverse transcribed into cDNA with the Reverse transcription kit (Promega, 
Hampshire, UK) according to manufacturer’s protocols.  
 
Real-Time quantitative PCR (qRT-PCR) 
 qRT-PCR was performed as previously described (Gemenetzidis et al. , 2009, Pantazi, 
Gemenetzidis, 2014). Samples were analyzed in triplicates and all primer sequences are 
listed in the Supplementary Data file (Supplementary Table S1).  
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Subcellular fractionation and Immunoblotting  
Cellular fractionation was performed using the Nuclear Extraction Kit (Imgenex, San 
Diego, CA) according to manufacturer’s protocol. Total cell protein extraction and 
immunoblot analysis was performed as previously described (Gemenetzidis, Bose, 2009, 
Pantazi, Gemenetzidis, 2014). All primary and secondary antibodies used are listed in 
Supplementary Data file (Supplementary Table S2).  
 
Luciferase Reporter Assay 
The luciferase reporter assay was performed as previously described (Teh et al. , 2007) 
and as described in Supplementary Material and Methods.  
 
Organotypic Cultures 
Three dimensional (3D) organotypic keratinocyte cultures on collagen gels were 
constructed, cultured, processed, sectioned, H&E-stained and imaged as previously 
described (Nystrom et al. , 2005) and as described in Supplementary Material and 
Methods. For the treatment with sFRP-1 (recombinant human sFRP-1 protein, CF; R&D 
Systems, UK), organotypic cultures were incubated with growth medium supplemented 
with 0.1 μg/ml sFRP-1 and medium was replaced every second day. Control gels were 
incubated with growth medium supplemented with vehicle (PBS 0.1%BSA).  
 
Immunofluorescence and confocal microscopy 
Cytokeratin was immunostained with a mouse monoclonal antibody (anti-human 
cytokeratin antibody AE1/AE3 (DakoCytomation) at 1:200 dilution, on 4μm paraffin 
sections as described in Supplementary Materials and Methods. Images were acquired 
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with a Zeiss LSM 710 Meta confocal microscope (Carl Zeiss Jena, Carl Zeiss Ltd, UK), 
using the Zen image processing and analysis software.  
 
Quantification of cell invasion  
Consecutive digital and fluorescence images of DAPI and cytokeratin stained sections 
were captured using a fluorescence confocal microscope (Zeiss LSM 710 Meta) across 
the whole length of the gel. Images were imported into ImageJ and cells were counted 
using the cell counter function. Cytokeratin and DAPI positive cells present below the 
basement membrane, were counted as invading cells, and a total count of invading cells 
per gel was derived. 8 (14-day) and 7 (28-day) collagen gels were counted for each cell 
line. 
 
Immunohistochemistry  
Immunohistochemistry was performed using an E-cadherin mouse monoclonal antibody 
(Flex, IS059, Ready to use, DakoCytomation), β-catenin mouse monoclonal antibody 
(Flex, IS702, Ready to use, DakoCytomation), MMP2 rabbit polyclonal antibody 
(ab37150, 1:100, Abcam) as described in Supplementary Material and Methods. Staining 
was imaged on the NanoZoomer Digital Pathology (NDP) whole slide scanner 
(Hamamatsu) in brightfield mode, using the Viewing Software NDP.view2 U12388-01 
image processing and analysis software.  
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Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s software, GraphPad’s InStat 
(V2-04a) and Prism Software (V5,0) (Graph-Pad Software, San Diego, CA) for student’s 
t test analysis.  
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Figure Legends 
 
Figure 1. GLI2ΔN induces nuclear re-localization of β-catenin and promotes its 
transcriptional activity. Immunoblotting for β-catenin, after cytoplasmic and nuclear 
protein fractionation on SINCE (a) and SINEG2 (b) cell lines, and on whole protein 
extracts (c). Lamin-B1 and GAPDH were used as nuclear and cytoplasmic markers, 
respectively, and β-actin was used as loading control. (d) Immunoblot densitometry 
analysis reveals a nearly 10-fold increase in the ratio of nuclear:cytoplasmic protein 
levels of β-catenin in SINEG2 cells, compared to SINCE cells. ** P≤0.01 (e) Luciferase 
reporter assay on N/TERT, SINCE and SINEG2 cells. OT-β-catenin responsive promoter 
was significantly induced in SINEG2 cells, compared to SINCE and N/TERT controls. 
Each bar represents a mean ± s.e.m of normalised to protein content triplicate samples. 
** P≤0.01. 
 
Figure 2: GLI2ΔN expression in N/TERT keratinocytes induces WNT genes 
expression. RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine 
the levels of WNT5A (a), WNT7A (b), and WNT11 (c) mRNA expression using primers 
specific for each gene. Quantitative RT-PCR analysis of WNT5A, WNT7A and WNT11 
showed an increase in expression of all the three genes in SINEG2 cells compared to 
N/TERT and SINCE control cells. Each bar represents mean fold induction relative to 
N/TERT (arbitrary value of 1) ± s.e.m of triplicate samples. *** P≤0.001.  
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Figure 3: Protein downregulation of E-cadherin and mRNA upregulation of 
SNAIL1 and SNAIL2 in GLI2ΔN-expressing keratinocytes. (a) SINEG2 cells show a 
marked decrease of E-cadherin protein levels compared to N/TERT and SINCE control 
cells. B-actin was used as a protein loading control. RNA was harvested from N/TERT, 
SINCE, and SINEG2 cells to examine the levels of SNAIL1 (b), SNAIL2 (c), and 
E-cadherin (c) mRNA expression using primers specific for each gene. Quantitative 
RT-PCR analysis of SNAIL1, SNAIL2 and E-cadherin showed an increase in expression 
of both SNAIL genes in SINEG2 cells compared to N/TERT and SINCE control cells, 
but no difference in expression of E-cadherin gene. Each bar represents mean fold 
induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate samples. 
** P≤0.01.  
 
Figure 4: Invasion of collagen/matrigel gels by GLI2ΔN-expressing cells. 14-day 
organotypic cultures of N/TERT, SINCE and SINEG2 cells, stained with (a) H&E 
staining (b) cytokeratin (red) and DAPI (blue), showing invasion of SINEG2 
keratinocytes. N/TERT and SINCE produced a stratified epithelium, whereas, SINEG2 
collectively invade into the gel. Scale bar: (a) 100µm, (b) 50µm. (c) Quantification of the 
total invading cell numbers at 14 days shows a significant increase of invading SINEG2 
cell numbers compared to control N/TERT and SINCE cells. Each data point represents 
the total number of invading cells per gel (n=8 from three independent experiments). 
Each bar represents the median with interquartile range of all data points. ** P≤0.01.  
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Figure 5: E-cadherin and β-catenin expression in 3D-organotypic cultures. Staining 
for (a) E-cadherin and (b) β-catenin in 14-day organotypic cultures of SINCE and 
SINEG2 cells. Expression of E-cadherin in SINCE cells (top panel) shows strong 
continuous membranous staining, compared to weaker expression in SINEG2 cell (lower 
two panels), showing loss or fragmentation of membranous E-cadherin staining. (b) 
Expression of β-catenin in SINCE cells (top panel) shows continuous membranous 
staining, compared to SINEG2 cells (lower two panels) showing loss or partial loss of 
membranous β-catenin staining with altered cellular distribution in the cytoplasm and (c) 
focally in the nucleus (black arrow). Scale bar: (a, b) 100µm, (c) 10µm. 
 
Figure 6: GLI2ΔN induces extended epidermal regeneration, in long-term 
organotypic cultures and an undifferentiated stem-cell like gene expression profile 
in vitro. 28-day organotypic cultures stained with (a) H&E, (b) cytokeratin (red) and 
DAPI (blue), shows epidermal atrophy of N/TERT and SINCE cells,, while SINEG cells 
display a stratified epithelium with collective keratinocyte invasion. (c) Deep single-cell 
invasion (white arrow) and multicellular solid strand invasion (yellow arrow) was also 
observed in 28-day collagen gels (SINEG2). Scale bar: (a) 100µm, (b) 50µm, (c, e) 
100µm. A significant increase in invading SINEG2 cells compared to N/TERT and 
SINCE cells is shown in (d). Each data point represents the total number of invading cells 
per gel (n=7) from two independent experiments. Each bar represents the median with 
interquartile range of all data points. ** P≤0.01. Involucrin (f), c-MYC (g), Integrin β1 
(h) and SOX2 (i) expression in SINEG2 cells. Each bar represents mean fold 
suppression/or induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate 
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samples. * P≤0.05, *** P≤0.001. (j) C-MYC protein levels were reduced in SINEG2 
cells. B-actin was used as loading control. 
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Table S1: Real-time quantitative PCR primers      
 
Genes 
Forward (F) and Reversed (R) 
Primer Nucleotide Sequence (5’-3’) 
Product (bp) 
c-MYC-F 
c-MYC-R 
TTTTTCGGGTAGTGGAAAACC 
GAGGTCATAGTTCCTGTTGGTG 
80 
Cyclin D1-F 
Cyclin D1-R 
TGTCCTACTACCGCCTCACA 
CAGGGCTTCGATCTGCTC 
92 
E-CADHERIN-F 
E-CADHERIN-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00080143 
84 
Integrin β1-F 
Integrin β1-R 
CGATGCCATCATGCAAGT 
AGTGAAACCCGGCATCTG 
95 
IVL-F 
IVL-R 
TGCCTGAGCAAGAATGTGAG 
TTCCTCATGCTGTTCCCAGT 
83 
MMP2-F 
MMP2-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00088396 
95 
POLR2A-F 
POLR2A-R 
GCAAATTCACCAAGAGAGACG 
CACGTCGACAGGAACATCAG 
72 
SNAIL1-F 
SNAIL1-R 
GCTGCAGGACTCTAATCCAGA 
ATCTCCGGAGGTGGGATG 
84 
SNAIL2-F 
SNAIL2-R 
ACAGCGAACTGGACACACAT 
GATGGGGCTGTATGCTCCT 
113 
SOX2-F 
SOX2-R 
GGGGGAATGGACCTTGTATAG 
GCAAAGCTCCTACCGTACCA 
85 
 1 
WNT11-F 
WNT11-R 
TGTGCTATGGCATCAAGTGG 
GCACCTGTGCAGACACCA 
108 
WNT5A-F 
WNT5A-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00025109 
105 
WNT7A-F 
WNT7A-R 
GGGACTATGAACCGGAAAGC 
CCAGAGCTACCACTGAGGAGA 
103 
YAP1-F 
YAP1-R 
CCCAGATGAACGTCACAGC 
GATTCTCTGGTTCATGGCTGA 
82 
 
* N/A: Not applicable  
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Table S2: Western blot antibodies 
Antigen Supplier and Antibody (Cat. No) 
Active-β- 
catenin 
Anti-Active-β-catenin (anti-ABC), clone 8E7, 
05-665, mouse monoclonal, 
Upstate, 
Lake Placid, 
NY, USA 
β-actin 
Anti-β-actin (AC-15) 
A1978, mouse monoclonal, 
Sigma-Aldrich, Dorset, 
UK 
β-catenin 
Anti-beta-catenin  
13-8400, mouse monoclonal, 
Zymed, 
San Fransisco, CA, USA 
c-MYC 
 Anti-c-MYC (9E10) 
sc-40, mouse monoclonal, 
Santa Cruz, Heidelberg, Germany 
E-cadherin 
Anti-E-cadherin (HECD-1) 
ab1416, mouse monoclonal, 
Abcam, Cambridge, UK 
EGFP 
Anti-EGFP 
ab-290, rabbit polyclonal, 
Abcam, Cambridge, UK 
GAPDH 
Anti-GAPDH 
ab9485, rabbit polyclonal, 
Abcam, Cambridge, UK 
Lamin-β1 
Anti-Lamin-β1 
IMG-5133A, rabbit polyclonal, 
Imgenex, 
San Diego, 
CA, USA 
 
Secondary HRP antibodies were as follows: polyclonal rabbit anti-mouse 
immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK) and polyclonal goat anti-
rabbit immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK). 
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Supplementary Material and Methods 
Plasmids and cloning 
The pCMV-EGFP-GLI2ΔN expression vector was a kind gift of Prof. Fritz Aberger 
(Department of Molecular Biology, University of Salzburg, Austria). The 
pSIN-CMV-EGFP plasmid (Deng et al. , 1997), was kindly provided by Prof. Paul Khavari 
(Stanford University School of Medicine, CA). The pSIN-MCS vector, containing an MCS 
insert, was cloned from pSIN-CMV-EGFP plasmid (Deng, Lin, 1997). The 
pSIN-CMV-GLI2ΔN stable expression retroviral transduction vector was obtained as 
previously described (Pantazi, Gemenetzidis, 2014). The retroviral regulatory tTA vector 
(pRevTet-Off) and the retroviral response cloning vector (pRev-TRE) were all purchased 
from Clontech Laboratories, Palo Alto, CA as part of the Rev Tet-Off System (Chang et 
al. , 2000, Chi et al. , 2005). The pTRE-CMV-EGFP-GLI2ΔN inducible expression 
retroviral transduction vector was obtained by introducing a BamHI site between the NheI 
and EcoRV sites in pCMV-EGFP-GLI2ΔN by a linker oligonucleotide, excising the ORF 
with BamHI and subcloning it into the pRevTRE vector cut with BamHI. The Tcf-4 
responsive luciferase plasmid pGL3-OT (OT-β-catenin responsive promoter), an improved 
version of TOPFLASH (Shih, Yu, 2000), which contains the TCF-4 binding sites (He, 
Sparks, 1998, Korinek et al. , 1997, Shih, Yu, 2000) was kindly provided by Bert 
Vogelstein (The John Hopkins Oncology Centre Baltimore, MD). The pSIN-OT-
Luciferase (pSIN-OT-Luc) reporter transduction vector was obtained by excising the 
OT-Luc cassette from pGL3-OT, with XmaI, NgoMIV and subcloning it into the NgoMIV 
linearized pSIN-MCS. 
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Cell lines and culture 
PT67 packaging cells, derived from an NH/3H3-based line expressing the 10A1 virus 
envelope, were purchased from (Clontech) as part of the Rev Tet-Off System (Chang, 
Jakobi, 2000, Chi, Chen, 2005) and cultured similarly to Phoenix cells as previously 
describe described (Pantazi, Gemenetzidis, 2014). The N/TERT 
RevTRE-CMV-EGFP-GLI2ΔN inducible cell line, referred to as NTEG2 cell line, was 
prepared as recommended by the kit manufacturer (RevTet-Off System, Clontech) (Chang, 
Jakobi, 2000, Chi, Chen, 2005). The retrovirus-mediated tet-regulated gene expression 
system (RevTet-Off) (Clontech) combines the advantages of retroviral transfer with those 
of tet-regulation and thus allows efficient and tight quantitative and temporal control of 
gene expression. In the RevTet-Off system, transcription of the gene of interest (in this 
study EGFP-GLI2ΔN fusion gene) is turned off in the presence of doxycycline (Dox) (a 
derivative of tetracycline) (NTEG2 Dox+), while transcription of this gene 
(EGFP-GLI2ΔN fusion gene) is turned on in the absence of doxycycline (NTEG2 Dox-). 
NTEG2 cells were maintained in RM+ growth media (DMEM supplemented with 
25% (v/v) Ham’s F12 medium (PAA), 10% (v/v) FCS (Biosera), 1% (v/v) Glutamine 
(PAA), 1% (v/v) penicillin/streptomycin (PAA), various mitogens (0.4µg/ml 
hydrocortisone (Sigma-Aldrich), 0.1nM cholera toxin (BioMol, Exeter, UK), 5µg/ml 
transferrin (Sigma), 20pM liothyronine (Sigma), 5µg/ml insulin (Sigma) and 10ng/ml 
epidermal growth factor (AbD Serotec, Kidlington, UK), in the presence of 50μg/ml 
Hygromycin B (Clontech) and 250μg/ml G418 (Clontech) and kept under Doxycycline 
(40ng/ml) (Clontech) repression for maintenance and characterisation studies. Due to the 
heterogeneity of the cell population, a higher concentration of Dox (10μg/ml) (Clontech) 
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was used to maximize repression in subsequent experiments. To induce expression cells 
were cultured in the absence of doxycycline in a medium containing 10% (v/v) Tet System 
Approved fetal bovine serum (Clontech). Thus, when doxycycline was removed, the 
inducible cell line (NTEG2 Dox-) was cultured in DMEM supplemented with 25% (v/v) 
Ham’s F12 medium (PAA), 10% (v/v) Tet System Approved fetal bovine serum (Tet-FBS) 
(Clontech), 1% (v/v) glutamine (PAA), 1% (v/v) penicillin/streptomycin (PAA), 50μg/ml 
Hygromycin B (Clontech) and 250μg/ml G418 (Clontech) and various mitogens (0.4µg/ml 
hydrocortisone (Sigma), 0.1nM cholera toxin (BioMol), 5µg/ml transferrin (Sigma), 20pM 
liothyronine (Sigma), 5µg/ml insulin (Sigma) and 10ng/ml epidermal growth factor (AbD 
Serotec). All cells were grown at 37oC in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. NTEG2 Dox- cells were further selected by FACS sorting and cultured 
under the presence of doxycycline, until required. NTEG2 cells were further transduced 
with the pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral plasmid, to produce the reporter 
inducible cell line (NTEG2-OTLuc). The reporter inducible cell line was then cultured in 
RM+ growth medium, containing 50μg/ml Hygromycin B (Clontech), 250μg/ml G418 
(Clontech), and kept under Doxycycline (Clontech) repression until required for 
experiments. All cells were grown at 37oC in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air.  
 
Retroviral Infection 
N/TERT cells were stably transduced with retroviruses encoding 
pRevTRE-CMV-EGFP-GLI2ΔN and pRevTet-Off plasmids, according to the kit 
manufacturer (RevTet-Off System, Clontech) (Chang, Jakobi, 2000, Chi, Chen, 2005)  and 
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as previously described in Pantazi et al 2014 (Pantazi, Gemenetzidis, 2014) to yield the 
N/TERT RevTRE-CMV-EGFP-GLI2ΔN (NTEG2) inducible cell line. Retroviral 
supernatant was obtained as previously described (Pantazi, Gemenetzidis, 2014), but using 
PT67 packaging cell line (Clontech) (Miller and Chen, 1996), instead of Phoenix A 
packaging cells. Briefly, N/TERT cells were pre transduced with the regulatory vector 
pRevTet-Off (Clontech), to yield the founder cell line NT-TetOff. The founder cell line 
was selected with 500µg/ml G418 (Clontech), and then transduced with the expression 
vector pRevTRE-CMV-EGFP-GLI2ΔN (RevTRE response plasmid) and selected with 
100µg/ml Hygromycin B (Clontech), to yield the NTEG2 inducible cell line. All 
transductions using pSIN based constructs were carried out as previously described 
(Pantazi, Gemenetzidis, 2014). 
 
Luciferase Reporter Assay 
In this study, the pGL3-OT was cloned into pSIN retroviral vector and luciferase was used 
to detect and measure the activity of the OT promoter, and indirectly the transcriptional 
activity of β-catenin (pSIN-OT-Luciferase). NTERT, SINCE, SINEG2 cells were 
transduced with pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral plasmid, and were left to 
express the transgene for 72h prior to harvesting for luciferase activity and protein content 
measurement. NTERT, SINEG2, SINCE  transduced cells were split and seeded in 6-well 
plates (16.8 x 104cells/well) 48h after viral infection and the next day (72h post-infection) 
cells were lysed and examined for luciferase activity and protein content. Similarly, 
N/TERT and NTEG2 cells were transduced with pSIN-OT-Luciferase (pSIN-OT-Luc) 
retroviral plasmid, and were left to express the transgene for 5 days prior to harvesting for 
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luciferase activity and protein content measurement. N/TERT and NTEG2 transduced cells 
were split and seeded in 6-well plates (4.2x104 cells/well) 48h after viral infection and the 
next day (72h post-infection) doxycycline was removed from transduced cells for another 
48hr (NTEG2 Dox-). Day 5 post-transduction, cells were lysed and examined for luciferase 
activity and protein content. All cell lysates were prepared using the Reporter 1x Lysis 
Buffer (Promega) and assayed for protein content and luciferase activity using the Bio-Rad 
Protein Assay System (BioRad, Hertfordshire, UK) and the Bright-GloTM Luciferase Assay 
System (Promega) respectively, according to manufacturer’s protocol. Luminescence 
values were determined using a FLUOSTAR OPTIMA microplate reader (BMG 
LABTECH, Aylesbury, UK). Luminescence data of each sample were normalized to 
protein content (luciferase/μg). 
 
Organotypic cultures 
NTERT, SINCE and SINEG2 cells were grown with dermal human fibroblasts in 
organotypic 3D cultures, under conditions that support the proliferation and differentiation 
of epidermal keratinocytes and mimic their in vivo pattern of growth and differentiation. 
Briefly, collagen gels were prepared by mixing 7 volumes of collagen/matrigel 
(75% Collagen type I and 25% Matrigel, BD Bioscience) with 1 volume 10× DMEM 
(Invitogen, Paisley, UK), 1 volume FCS (Biosera), and 1 volume FGM in which HFF had 
been suspended at a concentration of 5 × 106/ml. Then 1ml of this solution (0.5 × 106 HFF) 
was aliquoted into wells of a 24-well plate and allowed to polymerise for 30 min at 37 ◦C. 
After polymerization, 1ml of FGM was added per well and gels were left for 18 h at 37◦C 
to equilibrate or 0.5x106 of either N/TERT or SINCE or SINEG2 keratinocytes suspended  
 8 
in 1ml of  RM+ growth medium were seeded on top of each collagen gel. After 24h, gels 
were removed from the 24-well plates and placed on to individual collagen coated nylon 
discs resting on steel grids placed in six-well plates. Sufficient RM+ growth medium was 
added to reach the lower surface of the grid allowing the epithelial layer to grow at an air-
liquid interface. Medium was changed every 2 days. Gels were harvested at day 14 and 
day 28 and fixed in 4% formaldehyde (Sigma) overnight. The organotypic cultures were 
bisected vertically and embedded in paraffin wax on their cut surface for sectioning. 4μm 
sections were cut from the organotypic cultures paraffin blocks and transferred to charged 
microscope slides for H&E or immuno- staining, to determine the invasion index, protein 
expression, as well as any phenotypic changes. Organotypic culture processing (wax 
embedding), sectioning, and H&E staining were all occurred at the Pathology Department 
of the Institute of Cancer, Barts and the London School of Medicine and Dentistry, 
Charterhouse square, London, UK. The H&E stained slides were imaged on the 
NanoZoomer Digital Pathology (NDP) whole slide scanner (Hamamatsu Photonics UK 
Limited, Hertfotdsire, UK), in brightfield mode and images were processed and analyzed 
using the Viewing Software NDP.view2 U12388-01.  
 
Cytokeratin Immnunofluorescence in organotypic cultures 
Briefly,  paraffin embedded organotypic raft sections were initially heated at 60°C for 
10 minutes and were then deparaffinised in Xylene (2×5 minutes) and dehydrated 
(100% ethanol (2x), 90% ethanol, 70% ethanol, 50% ethanol for 5 minutes each) prior to 
rehydrated in distilled water (5 minutes). Antigen unmasking was performed by incubation 
in sub-boiling temperature for 20 minutes in antigen retrieval solution (pH 6.0; 
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DakoCytomation). The sections were washed twice in PBS and blocked by 5% goat serum 
(Sigma) in PBS (PAA) with 0.05% Tween-20 (T) (Sigma) and 0.1% BSA (PAA) for 1 
hour at room temperature (RT). Incubation with primary antibody in 1x 
PBS/0.05% T/0.1% BSA was performed for 2 hours at RT or overnight at 4°C. Sections 
were washed 3x5 minutes in 1x PBS/T, prior to incubation with Alexa Fluor 568 goat anti-
mouse IgG (H+L) secondary antibody (Invitrogen) at 1:500 dilution in 1x 
PBS/0.05% T/0.1% BSA, for 1 hour at RT. Finally, sections were washed 3x5 minutes in 
1x PBS/T and mounted with Prolong Gold Antifade Reagent Solution containing DAPI 
dilactate (Invitrogen). 
 
Sectioning and Immunohistochemistry analysis in 3D cultures 
Sectioning, immunostaining and imaging were performed at the Blizard Core Pathology 
Department, Queen Mary University of London, according to local standard protocols. 
Briefly, immunohistochemistry was carried out on 4µm sections (cut from the organotypic 
cultures processed in paraffin blocks) that were mounted on electrically charged slides 
(VWR, Leicestershire, UK) and dried overnight in a 60°C oven. The sections were stained 
on a DAKO Autostainer with the DAKO Flex+ Envision high pH Kit (K8012, 
DakoCytomation). The sections were antigen retrieved in the DAKO link machine (using 
the high pH from the kit above and at the factory settings) and then stained on the DAKO 
autostainer where the slides are treated with H2O2, primary antibody, linker, polymer 
secondary and visualised with DAB; all components (except primary antibodies) are from 
the kit and used at the times recommended. The sections were then counterstained with 
Gills Haematoxylin (In house preparation), dehydrated and cleared on a Gemini 
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Autostainer (Thermo Fisher, Leicestershire, UK) and cover-slipped with a xylene based 
mountant.  
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Supplementary Results 
Generation and characterization of the inducible NTEG2 cell line 
The preparation of the inducible cell line NTEG2 was based on the RevTet-OFF regulatory 
system, which allows efficient and tight quantitative and temporal control of gene 
expression. With this inducible system the transcription of the gene of interest (in this study 
EGFP-GLI2ΔN fusion gene) is turned off in the presence of doxycycline (Dox) (NTEG2 
Dox+), while transcription of this gene (EGFP-GLI2ΔN fusion gene) is turned on in the 
absence of doxycycline (NTEG2 Dox-) (Supplementary Figure S2a). For the generation of 
the NTEG2 cell line we used heterogeneous cell populations in order to avoid any clone 
specific effects. Following drug selection and induction, NTEG2 cells were FACS sorted, 
and all EGFP+ cells were collected using N/TERT as a reference cell line to obtain baseline 
values of green fluorescence, replated and cultured under the presence of doxycycline. 
 
Significant induction of protein levels was evidenced under fluorescent microscopy, 5 days 
after Dox removal (Supplementary Figure S2b; Dox(-) panels), while no induction of 
EGFP-GLI2ΔN fusion protein was observed in NTEG2 cells under the presence of 
doxycycline (Supplementary Figure S2b; Dox(+) panel). Flow cytometry analysis of 
NTEG2 cells showed an increased percentage of EGFP+ cells when Dox was removed, but 
also a small baseline induction of fluorescence even in Dox treated cells (Supplementary 
Figure S2c). Immunoblotting for EGFP-GLI2ΔN fusion protein confirmed GLI2ΔN 
induction in NTEG2 cells upon removal of Dox in comparison with baseline leak 
(Supplementary Figure S2d). Because we used pooled (FACS sorted EGFP+) NTEG2 
cells, variation was observed in the levels of GLI2ΔN expression (EGFP intensity) between 
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different clones in NTEG2 culture (Supplementary Figure S2b compare the two lower 
Dox(-) panels). To control for this variation we always measured levels of EGFP-GLI2ΔN 
induction/suppression by flow cytometry and immunoblotting prior to carrying out 
experiments to ensure similar levels of GLI2ΔN expression between experiments. 
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Supplementary Figure Legends 
 
Figure S1. Cyclin-D1 expression in GLI2ΔN-expressing keratinocytes. RNA was 
harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of Cyclin-D1 
mRNA expression. Quantitative RT-PCR analysis showed an increase in the expression of 
Cyclin-D1 in SINEG2 cells compared to N/TERT and SINCE control cells. Each bar 
represents a mean ± s.e.m of triplicate samples. * P≤0.05, ** P≤0.01. 
 
Figure S2. Generation and characterization of NTEG2 inducible cell line. (a) Diagram 
illustrating the principle of induction and/or repression of EGFP-GLI2ΔN fusion protein 
under the control of Doxycycline. Tetracycline controlled transactivator (tTa) binds to 
tetracycline response element (TRE) to activate transgene transcription mediated by the 
CMV promoter in the absence of doxycycline. tTa binding is repressed in the presence of 
doxycycline. (b) Representative pictures of NTEG2 cells in the presence (Dox(+)) or 
absence (Dox(-)) of doxycycline. Varying levels of EGFP-GLI2ΔN expression were 
observed possibly due to the heterogeneity of NTEG2 cell population.  (c) Flow cytometry 
analysis of NTEG2 cell line in the presence or absence of doxycycline. Clear induction of 
EGFP-GLI2ΔN is shown in Dox(-) cells while background activity of EGFP-GLI2ΔN is 
also evidenced in the presence of doxycycline (top panel; Q2 quartile) represented by the 
small population detected above threshold levels of fluorescence obtained from wild-type 
N/TERT cells. (d) Immunoblotting analysis of NTEG2 cells in the presence or absence 
(5 days) of doxycycline against anti-EGFP antibody (EGFP-GLI2ΔN fusion protein ~ 
180kDa), with β-actin (~ 42kDa) used as loading control. Significant induction of the 
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transgene is observed in Dox(-) cells, while background levels of induction are also present, 
as evidenced by previous flow cytometry analysis.  
 
Figure S3. GLI2ΔN induces β-catenin transcriptional activation. (a) Immunoblotting 
in NTEG2 inducible cell line against EGFP antibody (EGFP-GLI2ΔN fusion 
protein ~180kDa), in the presence or absence of doxycycline, for 48h. β-actin (~42kDa) 
was used as loading control. Results indicated high levels of EGFP-GLI2ΔN fusion protein 
inducibility before the experiment. 48h of doxycycline withdrawal was the time-point of 
choice in order to achieve significant induction of EGFP-GLI2ΔN and maximum 
expression of SIN-OT-Luc reporter vector. (b) Luciferase assay on N/TERT and NTEG2 
induced and uninduced cells. N/TERT keratinocytes were used as internal controls, due to 
background levels of GLI2ΔN in Dox+ NTEG2 cells. N/TERT and NTEG2 cells were 
transduced with SIN-OT-Luciferase vector and expressed the transgene for 72h, followed 
by doxycycline removal for another 48h. Day 5 post-transduction, lysates were prepared 
and examined for luciferase activity and protein content. OT-β-catenin responsive 
promoter was significantly activated in NTEG2 Dox- cells (~ 2.4 fold) compared to both 
N/TERT (*** P≤0.001) and NTEG2 Dox+ (** P≤0.01) cells. The increase in luciferase 
activity observed in uninduced NTEG2 cells (NTEG2 Dox+), compared to N/TERT cells 
can possibly be attributed to incomplete repression of GLI2ΔN in the presence of Dox. 
Each bar represents a mean ± s.e.m of normalised to protein content triplicate samples. (c) 
Active (dephosphorylated) β-catenin levels are increased in induced NTEG2 cells 
compared to the uninduced control cells. Active β-catenin levels in cell lysates from 
induced and uninduced NTEG2 cells were analysed by immunoblotting with anti-active-
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β-catenin antibody (~92kDa). The EGFP-GLI2ΔN protein levels after 48h removal of 
doxycycline are also shown for reference and β-actin was used as loading control.  
 
Figure S4. MMP2 expression in GLI2ΔN-expressing keratinocytes. (a) RNA was 
harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of MMP2 
mRNA expression. qRT-PCR analysis showed an increase in the expression of MMP2 in 
SINEG2 cells compared to N/TERT and SINCE control cells. Each bar represents mean 
fold induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate 
samples.** P≤0.01. (b) Immuno-histochemical staining for MMP2 in sections of 
organotypic cultures of control SINCE cells (top panel) and SINEG2 cells (lower two 
panels) grown in collagen/matrigel gels for 14 days. Increased MMP2 expression is seen 
in SINEG2 cells compared to SINCE control cells, and shows a more pronounced staining 
in the edges/periphery of the invading multicellular strands with a bud-like tip (blue arrow) 
and clusters (red arrow). Scale bar: 100µm. 
 
Figure S5. sFRP-1 blocks invasion of SINEG2 cells. 14-days organotypic cultures of 
SINEG2 cells treated with vehicle (top panel) or 0.1 μg/ml sFRP-1 (bottom panel). 
SIENG2 cells produce a thick basal-like undifferentiated epithelium in both conditions. 
When treated with vehicle only (top panel), SINEG2 cells display significant invasion 
capacity with clusters of cells invading the tissue, whereas treatment with sFRP-1 (bottom 
panel) reduces the capacity of SINEG2 cells to detach from the main bulk of the epithelium 
and invade into the organotypic ECM. 
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Table S1: Real-time quantitative PCR primers      
 
Genes 
Forward (F) and Reversed (R) 
Primer Nucleotide Sequence (5’-3’) 
Product (bp) 
c-MYC-F 
c-MYC-R 
TTTTTCGGGTAGTGGAAAACC 
GAGGTCATAGTTCCTGTTGGTG 
80 
Cyclin D1-F 
Cyclin D1-R 
TGTCCTACTACCGCCTCACA 
CAGGGCTTCGATCTGCTC 
92 
E-CADHERIN-F 
E-CADHERIN-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00080143 
84 
Integrin β1-F 
Integrin β1-R 
CGATGCCATCATGCAAGT 
AGTGAAACCCGGCATCTG 
95 
IVL-F 
IVL-R 
TGCCTGAGCAAGAATGTGAG 
TTCCTCATGCTGTTCCCAGT 
83 
MMP2-F 
MMP2-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00088396 
95 
POLR2A-F 
POLR2A-R 
GCAAATTCACCAAGAGAGACG 
CACGTCGACAGGAACATCAG 
72 
SNAIL1-F 
SNAIL1-R 
GCTGCAGGACTCTAATCCAGA 
ATCTCCGGAGGTGGGATG 
84 
SNAIL2-F 
SNAIL2-R 
ACAGCGAACTGGACACACAT 
GATGGGGCTGTATGCTCCT 
113 
SOX2-F 
SOX2-R 
GGGGGAATGGACCTTGTATAG 
GCAAAGCTCCTACCGTACCA 
85 
 1 
WNT11-F 
WNT11-R 
TGTGCTATGGCATCAAGTGG 
GCACCTGTGCAGACACCA 
108 
WNT5A-F 
WNT5A-R 
*N/A. Commercially available 
by Qiagen, West Sussex, UK 
Cat. No: QT00025109 
105 
WNT7A-F 
WNT7A-R 
GGGACTATGAACCGGAAAGC 
CCAGAGCTACCACTGAGGAGA 
103 
YAP1-F 
YAP1-R 
CCCAGATGAACGTCACAGC 
GATTCTCTGGTTCATGGCTGA 
82 
 
* N/A: Not applicable  
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Table S2: Western blot antibodies 
Antigen Supplier and Antibody (Cat. No) 
Active-β- 
catenin 
Anti-Active-β-catenin (anti-ABC), clone 8E7, 
05-665, mouse monoclonal, 
Upstate, 
Lake Placid, 
NY, USA 
β-actin 
Anti-β-actin (AC-15) 
A1978, mouse monoclonal, 
Sigma-Aldrich, Dorset, 
UK 
β-catenin 
Anti-beta-catenin  
13-8400, mouse monoclonal, 
Zymed, 
San Fransisco, CA, USA 
c-MYC 
 Anti-c-MYC (9E10) 
sc-40, mouse monoclonal, 
Santa Cruz, Heidelberg, Germany 
E-cadherin 
Anti-E-cadherin (HECD-1) 
ab1416, mouse monoclonal, 
Abcam, Cambridge, UK 
EGFP 
Anti-EGFP 
ab-290, rabbit polyclonal, 
Abcam, Cambridge, UK 
GAPDH 
Anti-GAPDH 
ab9485, rabbit polyclonal, 
Abcam, Cambridge, UK 
Lamin-β1 
Anti-Lamin-β1 
IMG-5133A, rabbit polyclonal, 
Imgenex, 
San Diego, 
CA, USA 
 
Secondary HRP antibodies were as follows: polyclonal rabbit anti-mouse 
immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK) and polyclonal goat anti-
rabbit immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK). 
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Supplementary Material and Methods 
Plasmids and cloning 
The pCMV-EGFP-GLI2ΔN expression vector was a kind gift of Prof. Fritz Aberger 
(Department of Molecular Biology, University of Salzburg, Austria). The 
pSIN-CMV-EGFP plasmid (Deng et al. , 1997), was kindly provided by Prof. Paul Khavari 
(Stanford University School of Medicine, CA). The pSIN-MCS vector, containing an MCS 
insert, was cloned from pSIN-CMV-EGFP plasmid (Deng, Lin, 1997). The 
pSIN-CMV-GLI2ΔN stable expression retroviral transduction vector was obtained as 
previously described (Pantazi, Gemenetzidis, 2014). The retroviral regulatory tTA vector 
(pRevTet-Off) and the retroviral response cloning vector (pRev-TRE) were all purchased 
from Clontech Laboratories, Palo Alto, CA as part of the Rev Tet-Off System (Chang et 
al. , 2000, Chi et al. , 2005). The pTRE-CMV-EGFP-GLI2ΔN inducible expression 
retroviral transduction vector was obtained by introducing a BamHI site between the NheI 
and EcoRV sites in pCMV-EGFP-GLI2ΔN by a linker oligonucleotide, excising the ORF 
with BamHI and subcloning it into the pRevTRE vector cut with BamHI. The Tcf-4 
responsive luciferase plasmid pGL3-OT (OT-β-catenin responsive promoter), an improved 
version of TOPFLASH (Shih, Yu, 2000), which contains the TCF-4 binding sites (He, 
Sparks, 1998, Korinek et al. , 1997, Shih, Yu, 2000) was kindly provided by Bert 
Vogelstein (The John Hopkins Oncology Centre Baltimore, MD). The pSIN-OT-
Luciferase (pSIN-OT-Luc) reporter transduction vector was obtained by excising the 
OT-Luc cassette from pGL3-OT, with XmaI, NgoMIV and subcloning it into the NgoMIV 
linearized pSIN-MCS. 
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Cell lines and culture 
PT67 packaging cells, derived from an NH/3H3-based line expressing the 10A1 virus 
envelope, were purchased from (Clontech) as part of the Rev Tet-Off System (Chang, 
Jakobi, 2000, Chi, Chen, 2005) and cultured similarly to Phoenix cells as previously 
describe described (Pantazi, Gemenetzidis, 2014). The N/TERT 
RevTRE-CMV-EGFP-GLI2ΔN inducible cell line, referred to as NTEG2 cell line, was 
prepared as recommended by the kit manufacturer (RevTet-Off System, Clontech) (Chang, 
Jakobi, 2000, Chi, Chen, 2005). The retrovirus-mediated tet-regulated gene expression 
system (RevTet-Off) (Clontech) combines the advantages of retroviral transfer with those 
of tet-regulation and thus allows efficient and tight quantitative and temporal control of 
gene expression. In the RevTet-Off system, transcription of the gene of interest (in this 
study EGFP-GLI2ΔN fusion gene) is turned off in the presence of doxycycline (Dox) (a 
derivative of tetracycline) (NTEG2 Dox+), while transcription of this gene 
(EGFP-GLI2ΔN fusion gene) is turned on in the absence of doxycycline (NTEG2 Dox-). 
NTEG2 cells were maintained in RM+ growth media (DMEM supplemented with 
25% (v/v) Ham’s F12 medium (PAA), 10% (v/v) FCS (Biosera), 1% (v/v) Glutamine 
(PAA), 1% (v/v) penicillin/streptomycin (PAA), various mitogens (0.4µg/ml 
hydrocortisone (Sigma-Aldrich), 0.1nM cholera toxin (BioMol, Exeter, UK), 5µg/ml 
transferrin (Sigma), 20pM liothyronine (Sigma), 5µg/ml insulin (Sigma) and 10ng/ml 
epidermal growth factor (AbD Serotec, Kidlington, UK), in the presence of 50μg/ml 
Hygromycin B (Clontech) and 250μg/ml G418 (Clontech) and kept under Doxycycline 
(40ng/ml) (Clontech) repression for maintenance and characterisation studies. Due to the 
heterogeneity of the cell population, a higher concentration of Dox (10μg/ml) (Clontech) 
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was used to maximize repression in subsequent experiments. To induce expression cells 
were cultured in the absence of doxycycline in a medium containing 10% (v/v) Tet System 
Approved fetal bovine serum (Clontech). Thus, when doxycycline was removed, the 
inducible cell line (NTEG2 Dox-) was cultured in DMEM supplemented with 25% (v/v) 
Ham’s F12 medium (PAA), 10% (v/v) Tet System Approved fetal bovine serum (Tet-FBS) 
(Clontech), 1% (v/v) glutamine (PAA), 1% (v/v) penicillin/streptomycin (PAA), 50μg/ml 
Hygromycin B (Clontech) and 250μg/ml G418 (Clontech) and various mitogens (0.4µg/ml 
hydrocortisone (Sigma), 0.1nM cholera toxin (BioMol), 5µg/ml transferrin (Sigma), 20pM 
liothyronine (Sigma), 5µg/ml insulin (Sigma) and 10ng/ml epidermal growth factor (AbD 
Serotec). All cells were grown at 37oC in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. NTEG2 Dox- cells were further selected by FACS sorting and cultured 
under the presence of doxycycline, until required. NTEG2 cells were further transduced 
with the pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral plasmid, to produce the reporter 
inducible cell line (NTEG2-OTLuc). The reporter inducible cell line was then cultured in 
RM+ growth medium, containing 50μg/ml Hygromycin B (Clontech), 250μg/ml G418 
(Clontech), and kept under Doxycycline (Clontech) repression until required for 
experiments. All cells were grown at 37oC in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air.  
 
Retroviral Infection 
N/TERT cells were stably transduced with retroviruses encoding 
pRevTRE-CMV-EGFP-GLI2ΔN and pRevTet-Off plasmids, according to the kit 
manufacturer (RevTet-Off System, Clontech) (Chang, Jakobi, 2000, Chi, Chen, 2005)  and 
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as previously described in Pantazi et al 2014 (Pantazi, Gemenetzidis, 2014) to yield the 
N/TERT RevTRE-CMV-EGFP-GLI2ΔN (NTEG2) inducible cell line. Retroviral 
supernatant was obtained as previously described (Pantazi, Gemenetzidis, 2014), but using 
PT67 packaging cell line (Clontech) (Miller and Chen, 1996), instead of Phoenix A 
packaging cells. Briefly, N/TERT cells were pre transduced with the regulatory vector 
pRevTet-Off (Clontech), to yield the founder cell line NT-TetOff. The founder cell line 
was selected with 500µg/ml G418 (Clontech), and then transduced with the expression 
vector pRevTRE-CMV-EGFP-GLI2ΔN (RevTRE response plasmid) and selected with 
100µg/ml Hygromycin B (Clontech), to yield the NTEG2 inducible cell line. All 
transductions using pSIN based constructs were carried out as previously described 
(Pantazi, Gemenetzidis, 2014). 
 
Luciferase Reporter Assay 
In this study, the pGL3-OT was cloned into pSIN retroviral vector and luciferase was used 
to detect and measure the activity of the OT promoter, and indirectly the transcriptional 
activity of β-catenin (pSIN-OT-Luciferase). NTERT, SINCE, SINEG2 cells were 
transduced with pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral plasmid, and were left to 
express the transgene for 72h prior to harvesting for luciferase activity and protein content 
measurement. NTERT, SINEG2, SINCE  transduced cells were split and seeded in 6-well 
plates (16.8 x 104cells/well) 48h after viral infection and the next day (72h post-infection) 
cells were lysed and examined for luciferase activity and protein content. Similarly, 
N/TERT and NTEG2 cells were transduced with pSIN-OT-Luciferase (pSIN-OT-Luc) 
retroviral plasmid, and were left to express the transgene for 5 days prior to harvesting for 
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luciferase activity and protein content measurement. N/TERT and NTEG2 transduced cells 
were split and seeded in 6-well plates (4.2x104 cells/well) 48h after viral infection and the 
next day (72h post-infection) doxycycline was removed from transduced cells for another 
48hr (NTEG2 Dox-). Day 5 post-transduction, cells were lysed and examined for luciferase 
activity and protein content. All cell lysates were prepared using the Reporter 1x Lysis 
Buffer (Promega) and assayed for protein content and luciferase activity using the Bio-Rad 
Protein Assay System (BioRad, Hertfordshire, UK) and the Bright-GloTM Luciferase Assay 
System (Promega) respectively, according to manufacturer’s protocol. Luminescence 
values were determined using a FLUOSTAR OPTIMA microplate reader (BMG 
LABTECH, Aylesbury, UK). Luminescence data of each sample were normalized to 
protein content (luciferase/μg). 
 
Organotypic cultures 
NTERT, SINCE and SINEG2 cells were grown with dermal human fibroblasts in 
organotypic 3D cultures, under conditions that support the proliferation and differentiation 
of epidermal keratinocytes and mimic their in vivo pattern of growth and differentiation. 
Briefly, collagen gels were prepared by mixing 7 volumes of collagen/matrigel 
(75% Collagen type I and 25% Matrigel, BD Bioscience) with 1 volume 10× DMEM 
(Invitogen, Paisley, UK), 1 volume FCS (Biosera), and 1 volume FGM in which HFF had 
been suspended at a concentration of 5 × 106/ml. Then 1ml of this solution (0.5 × 106 HFF) 
was aliquoted into wells of a 24-well plate and allowed to polymerise for 30 min at 37 ◦C. 
After polymerization, 1ml of FGM was added per well and gels were left for 18 h at 37◦C 
to equilibrate or 0.5x106 of either N/TERT or SINCE or SINEG2 keratinocytes suspended  
 8 
in 1ml of  RM+ growth medium were seeded on top of each collagen gel. After 24h, gels 
were removed from the 24-well plates and placed on to individual collagen coated nylon 
discs resting on steel grids placed in six-well plates. Sufficient RM+ growth medium was 
added to reach the lower surface of the grid allowing the epithelial layer to grow at an air-
liquid interface. Medium was changed every 2 days. Gels were harvested at day 14 and 
day 28 and fixed in 4% formaldehyde (Sigma) overnight. The organotypic cultures were 
bisected vertically and embedded in paraffin wax on their cut surface for sectioning. 4μm 
sections were cut from the organotypic cultures paraffin blocks and transferred to charged 
microscope slides for H&E or immuno- staining, to determine the invasion index, protein 
expression, as well as any phenotypic changes. Organotypic culture processing (wax 
embedding), sectioning, and H&E staining were all occurred at the Pathology Department 
of the Institute of Cancer, Barts and the London School of Medicine and Dentistry, 
Charterhouse square, London, UK. The H&E stained slides were imaged on the 
NanoZoomer Digital Pathology (NDP) whole slide scanner (Hamamatsu Photonics UK 
Limited, Hertfotdsire, UK), in brightfield mode and images were processed and analyzed 
using the Viewing Software NDP.view2 U12388-01.  
 
Cytokeratin Immnunofluorescence in organotypic cultures 
Briefly,  paraffin embedded organotypic raft sections were initially heated at 60°C for 
10 minutes and were then deparaffinised in Xylene (2×5 minutes) and dehydrated 
(100% ethanol (2x), 90% ethanol, 70% ethanol, 50% ethanol for 5 minutes each) prior to 
rehydrated in distilled water (5 minutes). Antigen unmasking was performed by incubation 
in sub-boiling temperature for 20 minutes in antigen retrieval solution (pH 6.0; 
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DakoCytomation). The sections were washed twice in PBS and blocked by 5% goat serum 
(Sigma) in PBS (PAA) with 0.05% Tween-20 (T) (Sigma) and 0.1% BSA (PAA) for 1 
hour at room temperature (RT). Incubation with primary antibody in 1x 
PBS/0.05% T/0.1% BSA was performed for 2 hours at RT or overnight at 4°C. Sections 
were washed 3x5 minutes in 1x PBS/T, prior to incubation with Alexa Fluor 568 goat anti-
mouse IgG (H+L) secondary antibody (Invitrogen) at 1:500 dilution in 1x 
PBS/0.05% T/0.1% BSA, for 1 hour at RT. Finally, sections were washed 3x5 minutes in 
1x PBS/T and mounted with Prolong Gold Antifade Reagent Solution containing DAPI 
dilactate (Invitrogen). 
 
Sectioning and Immunohistochemistry analysis in 3D cultures 
Sectioning, immunostaining and imaging were performed at the Blizard Core Pathology 
Department, Queen Mary University of London, according to local standard protocols. 
Briefly, immunohistochemistry was carried out on 4µm sections (cut from the organotypic 
cultures processed in paraffin blocks) that were mounted on electrically charged slides 
(VWR, Leicestershire, UK) and dried overnight in a 60°C oven. The sections were stained 
on a DAKO Autostainer with the DAKO Flex+ Envision high pH Kit (K8012, 
DakoCytomation). The sections were antigen retrieved in the DAKO link machine (using 
the high pH from the kit above and at the factory settings) and then stained on the DAKO 
autostainer where the slides are treated with H2O2, primary antibody, linker, polymer 
secondary and visualised with DAB; all components (except primary antibodies) are from 
the kit and used at the times recommended. The sections were then counterstained with 
Gills Haematoxylin (In house preparation), dehydrated and cleared on a Gemini 
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Autostainer (Thermo Fisher, Leicestershire, UK) and cover-slipped with a xylene based 
mountant.  
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Supplementary Results 
Generation and characterization of the inducible NTEG2 cell line 
The preparation of the inducible cell line NTEG2 was based on the RevTet-OFF regulatory 
system, which allows efficient and tight quantitative and temporal control of gene 
expression. With this inducible system the transcription of the gene of interest (in this study 
EGFP-GLI2ΔN fusion gene) is turned off in the presence of doxycycline (Dox) (NTEG2 
Dox+), while transcription of this gene (EGFP-GLI2ΔN fusion gene) is turned on in the 
absence of doxycycline (NTEG2 Dox-) (Supplementary Figure S2a). For the generation of 
the NTEG2 cell line we used heterogeneous cell populations in order to avoid any clone 
specific effects. Following drug selection and induction, NTEG2 cells were FACS sorted, 
and all EGFP+ cells were collected using N/TERT as a reference cell line to obtain baseline 
values of green fluorescence, replated and cultured under the presence of doxycycline. 
 
Significant induction of protein levels was evidenced under fluorescent microscopy, 5 days 
after Dox removal (Supplementary Figure S2b; Dox(-) panels), while no induction of 
EGFP-GLI2ΔN fusion protein was observed in NTEG2 cells under the presence of 
doxycycline (Supplementary Figure S2b; Dox(+) panel). Flow cytometry analysis of 
NTEG2 cells showed an increased percentage of EGFP+ cells when Dox was removed, but 
also a small baseline induction of fluorescence even in Dox treated cells (Supplementary 
Figure S2c). Immunoblotting for EGFP-GLI2ΔN fusion protein confirmed GLI2ΔN 
induction in NTEG2 cells upon removal of Dox in comparison with baseline leak 
(Supplementary Figure S2d). Because we used pooled (FACS sorted EGFP+) NTEG2 
cells, variation was observed in the levels of GLI2ΔN expression (EGFP intensity) between 
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different clones in NTEG2 culture (Supplementary Figure S2b compare the two lower 
Dox(-) panels). To control for this variation we always measured levels of EGFP-GLI2ΔN 
induction/suppression by flow cytometry and immunoblotting prior to carrying out 
experiments to ensure similar levels of GLI2ΔN expression between experiments. 
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Supplementary Figure Legends 
 
Figure S1. Cyclin-D1 expression in GLI2ΔN-expressing keratinocytes. RNA was 
harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of Cyclin-D1 
mRNA expression. Quantitative RT-PCR analysis showed an increase in the expression 
of Cyclin-D1 in SINEG2 cells compared to N/TERT and SINCE control cells. Each bar 
represents a mean ± s.e.m of triplicate samples. * P≤0.05, ** P≤0.01. 
 
Figure S2. Generation and characterization of NTEG2 inducible cell line. (a) Diagram 
illustrating the principle of induction and/or repression of EGFP-GLI2ΔN fusion protein 
under the control of Doxycycline. Tetracycline controlled transactivator (tTa) binds to 
tetracycline response element (TRE) to activate transgene transcription mediated by the 
CMV promoter in the absence of doxycycline. tTa binding is repressed in the presence of 
doxycycline. (b) Representative pictures of NTEG2 cells in the presence (Dox(+)) or 
absence (Dox(-)) of doxycycline. Varying levels of EGFP-GLI2ΔN expression were 
observed possibly due to the heterogeneity of NTEG2 cell population.  (c) Flow cytometry 
analysis of NTEG2 cell line in the presence or absence of doxycycline. Clear induction of 
EGFP-GLI2ΔN is shown in Dox(-) cells while background activity of EGFP-GLI2ΔN is 
also evidenced in the presence of doxycycline (top panel; Q2 quartile) represented by the 
small population detected above threshold levels of fluorescence obtained from wild-type 
N/TERT cells. (d) Immunoblotting analysis of NTEG2 cells in the presence or absence 
(5 days) of doxycycline against anti-EGFP antibody (EGFP-GLI2ΔN fusion protein ~ 
180kDa), with β-actin (~ 42kDa) used as loading control. Significant induction of the 
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transgene is observed in Dox(-) cells, while background levels of induction are also present, 
as evidenced by previous flow cytometry analysis.  
 
Figure S3. GLI2ΔN induces β-catenin transcriptional activation. (a) Immunoblotting 
in NTEG2 inducible cell line against EGFP antibody (EGFP-GLI2ΔN fusion 
protein ~180kDa), in the presence or absence of doxycycline, for 48h. β-actin (~42kDa) 
was used as loading control. Results indicated high levels of EGFP-GLI2ΔN fusion protein 
inducibility before the experiment. 48h of doxycycline withdrawal was the time-point of 
choice in order to achieve significant induction of EGFP-GLI2ΔN and maximum 
expression of SIN-OT-Luc reporter vector. (b) Luciferase assay on N/TERT and NTEG2 
induced and uninduced cells. N/TERT keratinocytes were used as internal controls, due to 
background levels of GLI2ΔN in Dox+ NTEG2 cells. N/TERT and NTEG2 cells were 
transduced with SIN-OT-Luciferase vector and expressed the transgene for 72h, followed 
by doxycycline removal for another 48h. Day 5 post-transduction, lysates were prepared 
and examined for luciferase activity and protein content. OT-β-catenin responsive 
promoter was significantly activated in NTEG2 Dox- cells (~ 2.4 fold) compared to both 
N/TERT (*** P≤0.001) and NTEG2 Dox+ (** P≤0.01) cells. The increase in luciferase 
activity observed in uninduced NTEG2 cells (NTEG2 Dox+), compared to N/TERT cells 
can possibly be attributed to incomplete repression of GLI2ΔN in the presence of Dox. 
Each bar represents a mean ± s.e.m of normalised to protein content triplicate samples. (c) 
Active (dephosphorylated) β-catenin levels are increased in induced NTEG2 cells 
compared to the uninduced control cells. Active β-catenin levels in cell lysates from 
induced and uninduced NTEG2 cells were analysed by immunoblotting with anti-active-
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β-catenin antibody (~92kDa). The EGFP-GLI2ΔN protein levels after 48h removal of 
doxycycline are also shown for reference and β-actin was used as loading control.  
 
Figure S4. MMP2 expression in GLI2ΔN-expressing keratinocytes. (a) RNA was 
harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of MMP2 
mRNA expression. qRT-PCR analysis showed an increase in the expression of MMP2 in 
SINEG2 cells compared to N/TERT and SINCE control cells. Each bar represents mean 
fold induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate 
samples.** P≤0.01. (b) Immuno-histochemical staining for MMP2 in sections of 
organotypic cultures of control SINCE cells (top panel) and SINEG2 cells (lower two 
panels) grown in collagen/matrigel gels for 14 days. Increased MMP2 expression is seen 
in SINEG2 cells compared to SINCE control cells, and shows a more pronounced staining 
in the edges/periphery of the invading multicellular strands with a bud-like tip (blue arrow) 
and clusters (red arrow). Scale bar: 100µm. 
 
Figure S5. sFRP-1 blocks invasion of SINEG2 cells. 14-days organotypic cultures of 
SINEG2 cells treated with vehicle (top panel) or 0.1 μg/ml sFRP-1 (bottom panel). 
SIENG2 cells produce a thick basal-like undifferentiated epithelium in both conditions. 
When treated with vehicle only (top panel), SINEG2 cells display significant invasion 
capacity with clusters of cells invading the tissue, whereas treatment with sFRP-1 (bottom 
panel) reduces the capacity of SINEG2 cells to detach from the main bulk of the epithelium 
and invade into the organotypic ECM. 
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